Gadofosveset
Intravenous | |
ATC code | |
---|---|
Legal status | |
Legal status | |
Identifiers | |
| |
JSmol) | |
| |
|
Gadofosveset (trade names Vasovist, Ablavar) is a
gadolinium-based MRI contrast agent. It was used as the trisodium salt monohydrate form.[2][3] It acts as a blood pool agent by binding to human serum albumin. The manufacturer (Lantheus Medical) discontinued production in 2017 due to poor sales.[4]
Gadofosveset facilitates high-resolution magnetic resonance angiography.[5] Ferumoxytol (trade names Feraheme, Rienso), an intravenous iron-replacement therapy, has been shown to potentially be superior to gadofosveset as a blood pool agent for MR venography in pediatric patients.[6]
References
- FDA. Retrieved 22 Oct 2023.
- ^ DailyMed: Vasovist
- ^ Drugs.com: Ablavar
- ^ Bell D, Morgan M. "Gadofosveset trisodium". Radiopaedia. radiopaedia.org. Retrieved 2018-08-28.
- PMID 23701079.
- PMID 34936018.